AIUTI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 12.762
EU - Europa 2.701
AS - Asia 2.171
SA - Sud America 334
Continente sconosciuto - Info sul continente non disponibili 208
AF - Africa 31
OC - Oceania 4
Totale 18.211
Nazione #
US - Stati Uniti d'America 12.636
SG - Singapore 907
DE - Germania 880
CN - Cina 490
IT - Italia 351
RU - Federazione Russa 332
BR - Brasile 259
HK - Hong Kong 248
GB - Regno Unito 233
UA - Ucraina 221
IE - Irlanda 183
VN - Vietnam 163
FR - Francia 137
SE - Svezia 117
FI - Finlandia 89
BD - Bangladesh 81
CA - Canada 68
JP - Giappone 56
KR - Corea 43
IN - India 38
ES - Italia 33
AR - Argentina 27
NL - Olanda 25
AT - Austria 22
ID - Indonesia 22
IQ - Iraq 22
MX - Messico 22
TR - Turchia 22
BE - Belgio 19
EC - Ecuador 18
PL - Polonia 17
ZA - Sudafrica 14
UZ - Uzbekistan 9
CR - Costa Rica 8
IR - Iran 8
SA - Arabia Saudita 8
CL - Cile 7
JM - Giamaica 7
PE - Perù 7
PK - Pakistan 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
KG - Kirghizistan 6
LT - Lituania 6
PH - Filippine 6
AZ - Azerbaigian 4
BS - Bahamas 4
CO - Colombia 4
EE - Estonia 4
EU - Europa 4
IL - Israele 4
KE - Kenya 4
MY - Malesia 4
PY - Paraguay 4
SV - El Salvador 4
TW - Taiwan 4
AU - Australia 3
CZ - Repubblica Ceca 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
JO - Giordania 3
MA - Marocco 3
NG - Nigeria 3
RO - Romania 3
RS - Serbia 3
AL - Albania 2
AW - Aruba 2
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
EG - Egitto 2
GT - Guatemala 2
KZ - Kazakistan 2
LV - Lettonia 2
NI - Nicaragua 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
CG - Congo 1
CY - Cipro 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
KN - Saint Kitts e Nevis 1
MQ - Martinica 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 18.008
Città #
Woodbridge 2.527
Wilmington 2.526
Houston 2.404
Fairfield 620
Singapore 527
Ashburn 475
Ann Arbor 389
San Jose 353
Hong Kong 241
Seattle 240
Chandler 238
Cambridge 214
Jacksonville 194
Beijing 186
Dublin 167
Council Bluffs 143
Medford 125
Santa Clara 111
Rome 102
Dearborn 89
Los Angeles 67
New York 57
Buffalo 53
The Dalles 53
Lawrence 50
Tokyo 48
Ho Chi Minh City 46
Lauterbourg 41
Menlo Park 41
Hanoi 39
Munich 38
Helsinki 36
Dallas 35
Milan 33
Zhengzhou 33
Moscow 31
San Diego 30
São Paulo 30
Chicago 27
Nuremberg 26
Phoenix 25
Brooklyn 23
Mülheim 22
Denver 21
Frankfurt am Main 21
Shanghai 19
Toronto 19
Falls Church 18
Montreal 18
Brussels 17
London 17
Boardman 16
Monte Vista 16
Chongqing 15
Nanjing 15
Orem 15
Hefei 14
Redwood City 14
Jakarta 13
Norwalk 12
San Mateo 12
Amsterdam 11
North Bergen 11
University Park 11
Vienna 11
Barcelona 10
Manchester 10
Najaf 10
Warsaw 10
Atlanta 9
Da Nang 9
Dong Ket 9
Florence 9
Guangzhou 9
Stockholm 9
Belo Horizonte 8
Boston 8
Chennai 8
Johannesburg 8
Naples 8
San José 8
Ankara 7
Kingston 7
Mexico City 7
Mountain View 7
Philadelphia 7
Poplar 7
Redondo Beach 7
Rio de Janeiro 7
Verona 7
Baghdad 6
Elk Grove Village 6
Engelhard 6
Haiphong 6
Jinan 6
Kunming 6
Roubaix 6
Washington 6
Buenos Aires 5
Cleveland 5
Totale 13.354
Nome #
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome. 706
Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency 555
Gene therapy for immunodeficiency due to adenosine deaminase deficiency 541
Clinical features and follow-up in patients with 22q11.2 deletion syndrome 518
Chronic Granulomatous Disease Presenting with Salmonella Brain Abscesses. 513
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis 500
Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation. 496
Etiology, clinical outcome, and laboratory features in children with neutropenia: analysis of 104 cases 471
The Quality of Life of Children and Adolescents with X-Linked Agammaglobulinemia 468
In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency. 465
. Early-onset monocyte-B-natural killer-dendritic cells’ deficiency successfully treated with hematopoietic stem cell transaplantation 465
Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID 461
Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients 460
The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function 453
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 451
Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) 448
Successful treatment with percutaneous transhepatic alcoholization of a liver abscess in a child with chronic granulomatous disease 435
Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease 433
Long-Term Safety and Efficacy of Gene Therapyfor Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency 415
Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency 381
Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies 343
Severe Toxoplasma gondii infection in a member of a NFKB2-deficient family with T and B cell dysfunction 341
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front Immunol. 2019 Apr 11;10:316. doi: 10.3389/fimmu.2019.00316. eCollection 2019. Erratum in: Front Immunol. 2019 May 31;10:1184. 325
JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene 275
First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia 250
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment 245
Impaired X-CGD T cell compartment is gp91phox-NADPH oxidase independent 234
ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency 224
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy 221
Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: Analysis of function and distribution in lymphoid organs 216
How I treat ADA deficiency 210
Comprehensive genomic access to vector integration in clinical gene therapy. 208
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 204
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID 201
Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet) 199
Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy 198
Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection 195
Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency 190
Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy 187
Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. 183
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 181
Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models 175
Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID 174
Gene therapy for primary immunodeficiencies: Part 1 172
Gene therapy for adenosine deaminase deficiency. 167
Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott-Aldrich syndrome 164
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 164
Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell. 159
Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency. 158
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999-2019) 154
New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy. 153
Retroviral integrations in gene therapy trials 145
Gene therapy for primary immunodeficiencies: Part 2 143
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 125
Ten years of gene therapy for primary immuno deficiencies 124
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 120
SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity 117
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity 111
Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait? 106
SARS-CoV-2-related MIS-C: a key to the viral and genetic causes of Kawasaki disease? 101
Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression 96
A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis 91
Studying severe long COVID to understand post-infectious disorders beyond COVID-19 85
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 84
Harnessing type I IFN immunity against SARS-CoV-2 with early administration of IFN-β 80
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 80
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 79
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 75
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 70
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 70
From your nose to your toes: a review of severe acute respiratory syndrome Coronavirus 2 pandemic‒associated pernio 67
Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for diagnosing inborn errors of immunity 37
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 27
Long-term outcome in Wiskott-Aldrich syndrome and X-linked thrombocytopenia patients: an observational -prospective multi-center study of the Italian Primary Immune Deficiency Network (IPINET) 26
Machine learning–assisted diagnosis classification of primary immune dysregulation using IDDA2.1 phenotype profiling 25
Epidemiology and management of malignancies in patients with inborn errors of immunity—An ESID registry study of 19,959 patients 22
Totale 18.211
Categoria #
all - tutte 53.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.102


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022540 0 0 0 35 42 48 31 46 77 46 37 178
2022/2023716 80 54 24 79 54 177 70 38 61 10 48 21
2023/2024277 32 25 19 14 33 61 13 19 12 0 7 42
2024/20251.489 52 337 149 92 63 135 154 96 121 95 119 76
2025/20262.899 199 156 302 255 244 113 329 339 318 292 235 117
2026/20271.044 182 187 485 190 0 0 0 0 0 0 0 0
Totale 18.211